Wells Fargo Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Cuts Target Price to $19

Moomoo News13:43 ET · Ratings

ITeos Therapeutics Price Target Lowered to $19 From $31 at Wells Fargo

Yahoo FinanceDec 20 07:20 ET

Wells Fargo Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $19

BenzingaDec 19 09:58 ET · Ratings

ITeos Therapeutics Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow JonesDec 13 06:37 ET · Ratings

H.C. Wainwright Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Cuts Target Price to $21

Moomoo NewsDec 13 06:31 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on ITeos Therapeutics, Maintains $21 Price Target

BenzingaDec 13 06:27 ET